{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T15:23:42Z","timestamp":1771687422817,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005946","name":"Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fm0108008"],"award-info":[{"award-number":["JP19fm0108008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0108042"],"award-info":[{"award-number":["JP19fk0108042"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19jm0510001"],"award-info":[{"award-number":["JP19jm0510001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18jk0210005"],"award-info":[{"award-number":["JP18jk0210005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jiac.2019.10.013","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T09:10:27Z","timestamp":1576141827000},"page":"335-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae"],"prefix":"10.1016","volume":"26","author":[{"given":"Jong-Hoon","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Koide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetarou","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7439-5231","authenticated-orcid":false,"given":"Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9194-1062","authenticated-orcid":false,"given":"Chie","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1313-1494","authenticated-orcid":false,"given":"Yasuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.10.013_sref1","first-page":"501","article-title":"Global leprosy update, 2016: accelerating reduction of disease burden","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jiac.2019.10.013_bib1a","doi-asserted-by":"crossref","first-page":"269","DOI":"10.47276\/lr.83.3.269","article-title":"Drug-resistant leprosy: monitoring and current status","volume":"83","author":"Williams","year":"2012","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jiac.2019.10.013_bib1b","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199102073240606","article-title":"Fluoroquinolone antimicrobial agents","volume":"324","author":"Hooper","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2019.10.013_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jiac.2019.10.013_bib3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jac\/dkg222","article-title":"Mechanisms of resistance to quinolones: target\u00a0alterations, decreased accumulation and DNA gyrase protection","volume":"51","author":"Ruiz","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.01095-07","article-title":"Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?","volume":"52","author":"Matrat","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.05890-11","article-title":"Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae","volume":"56","author":"Yokoyama","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A\u00a0systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","article-title":"Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes","volume":"50","author":"Aubry","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib8","doi-asserted-by":"crossref","first-page":"e1838","DOI":"10.1371\/journal.pntd.0001838","article-title":"Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance","volume":"6","author":"Yokoyama","year":"2012","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.jiac.2019.10.013_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.47276\/lr.78.4.343","article-title":"The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines","volume":"78","author":"Matsuoka","year":"2007","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jiac.2019.10.013_bib10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JCM.06561-11","article-title":"Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients","volume":"50","author":"da Silva Rocha","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2019.10.013_bib11","first-page":"6","article-title":"Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea","volume":"50","author":"You","year":"2005","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2019.10.013_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/0378-6323.48656","article-title":"Relapse in leprosy","volume":"75","author":"Kaimal","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jiac.2019.10.013_bib13","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/AAC.44.10.2919-2921.2000","article-title":"Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice","volume":"44","author":"Consigny","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib14","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1128\/AAC.01162-07","article-title":"Powerful bactericidal activity of moxifloxacin in human leprosy","volume":"52","author":"Pardillo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib15","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/jm0205090","article-title":"A\u00a0novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group","volume":"46","author":"Kuramoto","year":"2003","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jiac.2019.10.013_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejmech.2015.08.015","article-title":"Discovery of WQ-3810: design, synthesis, and evaluation of 7-(3-alkylaminoazetidin-1-yl)fluoro-quinolones as orally active antibacterial agents","volume":"103","author":"Itoh","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiac.2019.10.013_bib17","doi-asserted-by":"crossref","first-page":"4C43","DOI":"10.1016\/j.ijantimicag.2014.07.017","article-title":"In\u00a0vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens","volume":"44","author":"Kazamori","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiac.2019.10.013_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.47276\/lr.81.2.137","article-title":"The history of Mycobacterium leprae Thai-53 strain","volume":"81","author":"Matsuoka","year":"2010","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jiac.2019.10.013_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005013","article-title":"DC-159a shows inhibitory activity against DNA gyrases of Mycobacterium leprae","volume":"10","author":"Yamaguchi","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.jiac.2019.10.013_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.01282-06","article-title":"Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones","volume":"51","author":"Matrat","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib21","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1128\/AAC.00042-11","article-title":"Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.013_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-59745-246-5_2","article-title":"Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities","volume":"142","author":"Fisher","year":"2008","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.jiac.2019.10.013_bib23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jiac.2019.10.013_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.jiac.2019.10.013_bib25","first-page":"125","volume":"76","author":"Nisha","year":"2018"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:10Z","timestamp":1761159550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19303307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1341321X19303307"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.013","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1341-321X(20)30116-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}